About Defibrotide
Class: | Antithrombotic agent, specifically a deoxyribonucleic acid (DNA) derivative
Use: | Treatment of hepatic veno-occlusive disease (VOD) in patients undergoing hematopoietic stem cell transplantation
Adult dose: | 25 mg/kg IV every 6 hours for 21 days
Pediatric dose: | 25 mg/kg IV every 6 hours for 21 days (same as adults)
Side effects: | Hypotension, fever, nausea, vomiting, diarrhea, headache, and bleeding
Contraindications: | Hypersensitivity to defibrotide or any component of
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.